Immune Checkpoint Inhibitors for the Treatment of Bladder CancerAntonio López-Beltrán, Rodolfo Montironi, Nuno Vau et al.|Cancers|2021Cited by 289
Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic FactorsMatteo Santoni, Nicola Battelli, Daniel Y.C. Heng et al.|Cancers|2019Cited by 31